Intellia Therapeutics Inc.

02/15/2022 | Press release | Distributed by Public on 02/15/2022 06:40

Intellia and ONK Therapeutics Announce Collaboration to Advance Allogeneic CRISPR-Edited NK Cell Therapies for the Treatment of Patients with Cancer